Delivery Order SPE2DB25D3017-SPE2DB25FVJYS
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,999.35 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packaging) on July 24, 2025, with completion scheduled for July 25, 2025. This non-set-aside, firm fixed-price delivery order represents a pharmaceutical supply transaction supporting federal medical procurement needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills the order from its...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,555.23 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packaging) on July 23, 2025, with completion scheduled for July 24, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $12,539.71 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 mg tablets (8-count packaging). This firm fixed price, non-set-aside contract was awarded on July 23, 2025, with an ultimate completion date of July 24, 2025. The contractor will perform this work at its corporate office location in Conshohocken, Pennsylvania. NURTEC ODT is a migraine treatment medication, consistent with AmerisourceBergen's extensive...
- The Defense Logistics Agency awarded a delivery order valued at $20,789.88 to AmerisourceBergen Drug Corp for 8 tablets of NURTEC ODT 75 mg, a migraine treatment medication. The contract was competitively awarded without set-aside status on July 21, 2025, with an ultimate completion date of July 22, 2025. Performance will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. This delivery order operates under a firm fixed-price structure, typical of the agency's pharmaceutical...
- The Defense Logistics Agency awarded a $6,469.16 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count packages). This award is non-competitive and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The contract will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $13,858.91 firm fixed price delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count units) with an ultimate completion date of July 28, 2025. This non-set-aside award was competitively awarded and represents a child order under AmerisourceBergen's larger pharmaceutical supply contract vehicle. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $29,813.65 to AmerisourceBergen Drug Corp for 8 tablets of NURTEC ODT 75 mg. This competitive, firm fixed-price delivery order was issued on July 24, 2025, with an ultimate completion date of July 25, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs for military and veteran healthcare systems. The delivery order is...
- The Defense Logistics Agency awarded a $24,953.82 delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packages) on July 22, 2025, with completion scheduled for July 23, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement needs across military and...
- The Defense Logistics Agency awarded a $23,545.12 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count units). This is a firm fixed-price, non-set-aside contract with performance completion targeted for July 28, 2025, and fulfillment from the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $89,299.27 to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8-count units) on July 18, 2025, with an ultimate completion date of July 21, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- SPE2DB25D3017Indefinite Delivery Contract
- SPE2DB25D3017-SPE2DB25FVJYSDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $10,145.63 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 MG Tablet 8s, a migraine treatment medication. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by July 24, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the delivery from its corporate office location in the same city. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply pharmaceuticals and medical supplies to support military healthcare programs worldwide. Through this prime contract vehicle, AmerisourceBergen Drug Corp provides critical medical commodities including specialty medications, brand-name and generic drugs, and vaccines to customers including the Defense Health Agency and U.S. Coast Guard, demonstrating the company's established capability to fulfill federal medical supply requirements through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.1k | 7/23/25 |